First exports to Brazil of India’s homegrown Bharat Biotech shot likely this week

Bharat Biotech has already supplied millions of doses of COVAXIN to its home government’s inoculation drive. The Indian government has also aggressively pushed exportation of locally-made vaccines.

RIO DE JANEIRO, BRAZIL - India’s Bharat Biotech said on Tuesday, February 9th that it was likely to export its COVID-19 vaccine to Brazil and the United Arab Emirates this week, a major success for the shot approved at home for emergency use, even without efficacy data from a late-stage trial now being conducted.

Bharat Biotech has already supplied millions of doses of COVAXIN, developed with the state-run Indian Council of Medical Research, to its home government’s inoculation drive. The government has also aggressively pushed exporting locally-made vaccines abroad as part of a diplomatic campaign . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?